Compared with other HER-2-negative subtypes, subtypes of HER2-positive cancer share a common mechanism of carcinogenesis characterized by decreased apoptosis and enhanced cell proliferation, mobility, invasiveness, metastasis, and angiogenesis (2). This evidence concerns the gene ERBB2 and cancer.